ReviewAbdominal radiology (New York)2026
Two-dimensional shear wave elastography in Fontan-associated liver disease: a narrative review.
Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single ventricle congenital heart defects are rare conditions that require surgical palliation following birth. Often, such defects require multistep surgical procedures in different stages of life. The Fontan operation, considered the final procedure for single ventricle congenital heart disease repair, has been associated with long-term complications to the liver despite its cardiac benefit. Fontan-associated liver disease (FALD) is considered the main hepatological complication post-Fontan surgery. Liver biopsy has been the gold standard for diagnosis. Ultrasound-based shear wave elastography (SWE) has been investigated as a non-invasive adjunct for liver stiffness assessment alongside serological, imaging, and histopathological parameters. This narrative review summarizes the current evidence regarding the use of SWE as a method to assess liver stiffness in FALD, including current applications, technical challenges, and limitations associated with its clinical implementation. Particular emphasis is placed on the confounding influence of hepatic congestion, the lack of validated FALD-specific stiffness thresholds, and the need for standardized acquisition and interpretation protocols.
Indexed as
Identifiers
42530594What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.